Physician profile
Mamie Mitscha
NPI 1386071264
$484.97
in general payments reported to CMS, 2019-2025
8 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $209 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.97 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $164.64 | 2025 | Trodelvy |
| Boston Scientific Corporation | $149.94 | 2024 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Takeda Pharmaceuticals U.S.A., INC. | $37.20 | 2025 | Iclusig |
| Coherus Oncology, INC. | $32.68 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $29.12 | 2025 | Enhertu |
| Novartis Pharmaceuticals Corporation | $25.94 | 2024 | |
| Servier Pharmaceuticals LLC | $24.78 | 2025 | |
| Incyte Corporation | $20.67 | 2025 | Jakafi, Niktimvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mamie Mitscha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.